J&J Cordis
This article was originally published in The Gray Sheet
Executive Summary
Stent delivery portfolio is enhanced with the launch of the ATW All Track Wire steerable guidewire, which promises to "deliver virtually any coronary artery stent and angioplasty balloon," Johnson & Johnson claims. The ATW offers improved ability to "drive, track and glide" compared to competing products, allowing a quicker and safer delivery to the target lesion, the firm maintains. The addition follows the April launch of the Mini Crown coronary stent and Dynasty stent delivery system, and the February launch of the Ninja balloon dilatation catheter
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.